118 related articles for article (PubMed ID: 35023434)
21. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
[TBL] [Abstract][Full Text] [Related]
22. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
[TBL] [Abstract][Full Text] [Related]
23. The Sterol Carrier Hydroxypropyl-β-Cyclodextrin Enhances the Metabolism of Phytosterols by Mycobacterium neoaurum.
Su L; Xu S; Shen Y; Xia M; Ren X; Wang L; Shang Z; Wang M
Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32414803
[TBL] [Abstract][Full Text] [Related]
24. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
Löscher W; Hönack D; Richter A; Schulz HU; Schürer M; Düsing R; Brewster ME
Epilepsia; 1995 Mar; 36(3):255-61. PubMed ID: 7614909
[TBL] [Abstract][Full Text] [Related]
25. Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs.
Müller BW; Albers E
J Pharm Sci; 1991 Jun; 80(6):599-604. PubMed ID: 1834826
[TBL] [Abstract][Full Text] [Related]
26. Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox
Berben P; Stappaerts J; Vink MJA; Domínguez-Vega E; Somsen GW; Brouwers J; Augustijns P
Eur J Pharm Biopharm; 2018 Nov; 132():231-236. PubMed ID: 29959034
[TBL] [Abstract][Full Text] [Related]
27. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
Hu L; Zhang H; Song W; Gu D; Hu Q
Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
[TBL] [Abstract][Full Text] [Related]
28. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
[TBL] [Abstract][Full Text] [Related]
29. Interaction of iodine with 2-hydroxypropyl-alpha-cyclodextrin and its bactericidal activity.
Tomono K; Goto H; Suzuki T; Ueda H; Nagai T; Watanabe J
Drug Dev Ind Pharm; 2002 Nov; 28(10):1303-9. PubMed ID: 12476876
[TBL] [Abstract][Full Text] [Related]
30. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.
Evrard B; Chiap P; DeTullio P; Ghalmi F; Piel G; Van Hees T; Crommen J; Losson B; Delattre L
J Control Release; 2002 Dec; 85(1-3):45-50. PubMed ID: 12480310
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin.
Chen M; Wu Q; Jiang J; Jin X; Liu S; Wang M; Zhao C
J Pharm Biomed Anal; 2017 Feb; 135():153-159. PubMed ID: 28027523
[TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
33. Anti-hyperalgesic and anti-inflammatory effects of citral with β-cyclodextrin and hydroxypropyl-β-cyclodextrin inclusion complexes in animal models.
Campos CA; Lima BS; Trindade GGG; Souza EPBSS; Mota DSA; Heimfarth L; Quintans JSS; Quintans-Júnior LJ; Sussuchi EM; Sarmento VHV; Carvalho FMS; Marreto RN; Costa RMR; Nunes RS; Araújo AAS; Shanmugam S; Thangaraj P
Life Sci; 2019 Jul; 229():139-148. PubMed ID: 31085246
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of Angelica sinensis extract in the presence of 2-hydroxypropyl-β-cyclodextrin.
Hsu CM; Tsai FJ; Tsai Y
Carbohydr Polym; 2014 Dec; 114():115-122. PubMed ID: 25263871
[TBL] [Abstract][Full Text] [Related]
35. Stabilization of the Metastable α-Form of Indomethacin Induced by the Addition of 2-Hydroxypropyl-β-Cyclodextrin, Causing Supersaturation (Spring) and Its Sustaining Deployment (Parachute).
Wada-Hirai A; Shimizu S; Ichii R; Tsunoda C; Hiroshige R; Fujita M; Li YP; Shimada Y; Otsuka Y; Goto S
J Pharm Sci; 2021 Nov; 110(11):3623-3630. PubMed ID: 34364701
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
[TBL] [Abstract][Full Text] [Related]
37. pH-dependent complexation of hydroxypropyl-beta-cyclodextrin with chlorin e6: effect on solubility and aggregation in relation to photodynamic efficacy.
Paul S; Heng PW; Chan LW
J Pharm Pharmacol; 2016 Apr; 68(4):439-49. PubMed ID: 26946047
[TBL] [Abstract][Full Text] [Related]
38. Complexation of steroid hormones with cyclodextrin derivatives: substituent effects of the guest molecule on solubility and stability in aqueous solution.
Albers E; Müller BW
J Pharm Sci; 1992 Aug; 81(8):756-61. PubMed ID: 1403720
[TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
Liu M; Cao W; Sun Y; He Z
Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
[TBL] [Abstract][Full Text] [Related]
40. Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream.
Taylor AM; Liu B; Mari Y; Liu B; Repa JJ
J Lipid Res; 2012 Nov; 53(11):2331-42. PubMed ID: 22892156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
